Showing results (461-470 of 5,804) with videos related to

Sort By:
Pageof 581
Drug Design, Development and Therapy|July 18, 2018
Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysisWeiran Dai, Ziliang Ye, Lang Li, et al.
Drug Design, Development and Therapy|June 9, 2018
5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agentsSobhi M Gomha, Mastoura M Edrees, Zeinab A Muhammad, et al.
Drug Design, Development and Therapy|June 9, 2018
Incidence and risk of cardiac toxicities in patients with relapsed and refractory multiple myeloma treated with carfilzomibFang Zhao, Bo Yang, Juan Wang, et al.
Drug Design, Development and Therapy|June 5, 2018
Expression and significance of the Hedgehog signal transduction pathway in oxygen-induced retinal neovascularization in miceMeilin Liu, Xiaolong Chen, Henan Liu, et al.
Drug Design, Development and Therapy|May 2, 2017
Humanin rescues cultured rat cortical neurons from NMDA-induced toxicity through the alleviation of mitochondrial dysfunctionAi-Ling Cui, Ying-Hua Zhang, Jian-Zhong Li, et al.
Drug Design, Development and Therapy|September 1, 2016
Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assayShih-Hsiang Lo, Kai-Chung Cheng, Ying-Xiao Li, et al.
Drug Design, Development and Therapy|August 27, 2016
Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapyAnna Szlachcic, Malgorzata Zakrzewska, Michal Lobocki, et al.
Drug Design, Development and Therapy|May 9, 2017
A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteersJieon Lee, Bo-Hyung Kim, Kyung-Sang Yu, et al.
Drug Design, Development and Therapy|May 13, 2017
Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical studyNaglaa El-Nabarawi, Mohamed El-Wakd, Mostafa Salem
Drug Design, Development and Therapy|July 12, 2017
Total flavonoids from Rhizoma Drynariae (Gusuibu) for treating osteoporotic fractures: implication in clinical practiceYili Zhang, Junjie Jiang, Hao Shen, et al.
Pageof 581